Tvardi Therapeutics, Inc.
TVRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001346830
No open-market purchases or sales by Tvardi Therapeutics, Inc. insiders were filed in the last 90 days; 57 institutions reported holding it in 13F filings for Q2 2026, worth $4.24M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Tvardi Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Tvardi Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wyzga Michael S | Director | – | Jun 11, 2026 | 1 |
| Shah Sujal | Director | – | Jun 11, 2026 | 1 |
| Smith Cynthia | Director | – | Jun 11, 2026 | 1 |
| Hall Wallace L Jr | Director | 202,044Indirect | Jun 11, 2026 | 1 |
| Shiff Susan Ph.D. | Director | 202,085 | Jun 11, 2026 | 1 |
| Kauh John Saewook M.D. | Chief Medical Officer | – | Feb 2, 2026 | 2 |
| Alibhai Imran Nizamudin | Chief Executive Officer | – | Feb 2, 2026 | 2 |
| O'Brien Stephen Paul | Principal Accounting Officer | – | Feb 2, 2026 | 2 |
| Conn Avi Daniel | Chief Financial Officer | – | Feb 2, 2026 | 2 |
| Tweardy Samuel David | 10% Owner | 0Indirect | Aug 5, 2025 | 0 |
| Wirk Shaheen | Director | 263,164Indirect | May 2, 2025 | 0 |
| Larson Jeffrey Leroy | SVP, Research & Development | – | Apr 21, 2025 | 0 |
| Chen Yixin | VP, Chem, Mfg and Ctrls | – | Apr 21, 2025 | 0 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | 7,190 | Mar 4, 2025 | 0 |
| Posner Christopher | PRESIDENT AND CEO | 13,109 | Mar 4, 2025 | 0 |
| Vogelbaum Martin | Director | 411,007 | Jun 6, 2024 | 0 |
| Ives Jeffrey L. | Director | 198,485 | Jun 6, 2024 | 0 |
| Boudreau Helen M | Director | 150,647 | Jun 6, 2024 | 0 |
| von Moltke Lisa | Director | 183,009 | Jun 6, 2024 | 0 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | 53,365 | Apr 9, 2024 | 0 |
| Maynard Ryan D | CHIEF FINANCIAL OFFICER | 8,012 | Feb 12, 2024 | 0 |
| Menzaghi Frederique Ph.D. | CHIEF SCIENTIFIC OFF,SVP-R&D | 167,247 | Feb 5, 2024 | 0 |
| Bains Harrison M Jr | Director | 57,438 | Jun 5, 2023 | 0 |
| Makara Richard | VP, Head of Accting;Controller | 13,583 | Jun 16, 2022 | 0 |
| Reilly Thomas Charles | Chief Financial Officer | 37,811 | Mar 4, 2022 | 0 |
| Chalmers Derek T | President & CEO | 991,405 | Sep 9, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 (view filing) | Feb 28 | 4 days | Posner ChristopherPRESIDENT AND CEO | SSale | −583 | $4.75 | −$2.77K | −4.3%13.1K after | |
| Mar 4, 2025 (view filing) | Feb 28 | 4 days | Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C. | SSale | −163 | $4.76 | −$775.88 | −2.2%7.19K after | |
| Feb 6, 2025 (view filing) | Feb 4 | 2 days | Posner ChristopherPRESIDENT AND CEO | SSale | −372 | $4.72 | −$1.76K | −2.6%13.7K after | |
| Nov 6, 2024 (view filing)4:51 PM ET | Nov 4 | 2 days | Posner ChristopherPRESIDENT AND CEO | SSale | −3.67K | $0.29 | −$1.06K | −2.1%168.8K after | |
| Aug 2, 2024 (view filing)4:05 PM ET | Aug 1 | 1 day | Posner ChristopherPRESIDENT AND CEO | SSale | −4.15K | $0.35 | −$1.45K | −2.3%172.4K after | |
| May 6, 2024 (view filing) | May 2 | 4 days | Posner ChristopherPRESIDENT AND CEO | SSale | −3.94K | $0.75 | −$2.95K | −2.2%176.6K after | |
| Apr 9, 2024 (view filing) | Apr 5 | 4 days | Goncalves JoanaCHIEF MEDICAL OFFICER | SSale | −2.75K | $0.83 | −$2.28K | −4.9%53.4K after | |
| Apr 9, 2024 (view filing) | Apr 5 | 4 days | Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C. | SSale | −2.75K | $0.83 | −$2.28K | −3.0%88.2K after | |
| Mar 4, 2024 (view filing) | Feb 29 | 4 days | Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C. | SSale | −3.29K | $0.89 | −$2.93K | −3.5%91.0K after | |
| Mar 4, 2024 (view filing) | Feb 29 | 4 days | Posner ChristopherPRESIDENT AND CEO | SSale | −5.83K | $0.89 | −$5.19K | −3.1%180.5K after | |
| Mar 4, 2024 (view filing) | Feb 29 | 4 days | Goncalves JoanaCHIEF MEDICAL OFFICER | SSale | −3.29K | $0.89 | −$2.93K | −5.5%56.1K after | |
| Feb 12, 2024 (view filing) | Feb 8, 2023 | 369 daysLate | Terrillion ScottSEC'Y; CHIEF COMPLIANCE & G.C. | SSale | −7.77K | $0.53 | −$4.12K | −7.6%94.3K after | |
| Feb 12, 2024 (view filing) | Feb 8, 2023 | 369 daysLate | Maynard Ryan DCHIEF FINANCIAL OFFICER | SSale | −5.49K | $0.53 | −$2.91K | −40.7%8.01K after | 10b5-1 |
| Feb 12, 2024 (view filing) | Feb 8, 2023 | 369 daysLate | Goncalves JoanaCHIEF MEDICAL OFFICER | SSale | −7.77K | $0.53 | −$4.12K | −11.6%59.4K after | |
| Feb 12, 2024 (view filing) | Feb 8 | 4 days | Posner ChristopherPRESIDENT AND CEO | SSale | −35.6K | $0.53 | −$18.9K | −16.0%186.4K after | |
| Feb 5, 2024 (view filing) | Feb 1 | 4 days | Posner ChristopherPRESIDENT AND CEO | SSale | −4.98K | $0.55 | −$2.74K | −2.2%221.9K after | |
| Nov 3, 2023 (view filing) | Nov 2 | 1 day | Posner ChristopherPresident and CEO | SSale | −3.80K | $1.22 | −$4.63K | −2.3%164.4K after | |
| Aug 4, 2023 (view filing) | Aug 3 | 1 day | Posner ChristopherPresident and CEO | SSale | −4.31K | $3.07 | −$13.2K | −2.5%168.2K after | 10b5-1 |
| Jun 27, 2023 (view filing) | Jun 23 | 4 days | Terrillion ScottSec'y; Chief Compliance & G.C. | SSale | −2.48K | $3.51 | −$8.72K | −2.7%88.6K after | 10b5-1 |
| Jun 27, 2023 (view filing) | Jun 23 | 4 days | Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D | SSale | −2.99K | $3.51 | −$10.5K | −1.9%153.7K after | 10b5-1 |
| Jun 27, 2023 (view filing) | Jun 23 | 4 days | Goncalves JoanaChief Medical Officer | SSale | −2.72K | $3.51 | −$9.56K | −4.8%53.7K after | 10b5-1 |
| May 9, 2023 (view filing) | May 5 | 4 days | Posner ChristopherPresident and CEO | SSale | −3.87K | $4.40 | −$17.0K | −2.2%172.5K after | 10b5-1 |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Terrillion ScottSec'y; Chief Compliance & G.C. | SSale | −2.48K | $4.91 | −$12.2K | −2.7%91.0K after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Goncalves JoanaChief Medical Officer | SSale | −2.48K | $4.91 | −$12.2K | −4.2%56.4K after | |
| Apr 6, 2023 (view filing) | Apr 4 | 2 days | Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D | SSale | −2.73K | $4.91 | −$13.4K | −1.7%156.7K after | |
| Mar 7, 2023 (view filing) | Mar 3 | 4 days | Posner ChristopherPresident and CEO | SSale | −5.99K | $9.71 | −$58.1K | −3.3%176.4K after | |
| Mar 7, 2023 (view filing) | Mar 3 | 4 days | Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D | SSale | −6.80K | $9.71 | −$66.0K | −4.1%159.5K after | |
| Mar 7, 2023 (view filing) | Mar 3 | 4 days | Terrillion ScottSec'y; Chief Compliance & G.C. | SSale | −6.26K | $9.71 | −$60.7K | −6.3%93.5K after | |
| Mar 7, 2023 (view filing) | Mar 3 | 4 days | Goncalves JoanaChief Medical Officer | SSale | −6.22K | $9.71 | −$60.4K | −9.6%58.9K after | |
| Feb 17, 2023 (view filing) | Feb 16 | 1 day | Goncalves JoanaChief Medical Officer | SSale | −2.27K | $10.20 | −$23.1K | −3.4%65.1K after | |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Posner ChristopherPresident and CEO | SSale | −4.19K | $11.80 | −$49.5K | −2.2%182.4K after | |
| Jan 19, 2023 (view filing) | Jan 17 | 2 days | Goncalves JoanaChief Medical Officer | SSale | −2.27K | $10.81 | −$24.5K | −3.3%67.4K after | |
| Jan 3, 2023 (view filing) | Dec 29, 2022 | 5 days | Goncalves JoanaChief Medical Officer | SSale | −2.27K | $10.18 | −$23.1K | −3.2%69.6K after | |
| Dec 23, 2022 (view filing) | Dec 21 | 2 days | Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D | SSale | −3.51K | $11.27 | −$39.5K | −2.1%166.3K after | |
| Dec 23, 2022 (view filing) | Dec 21 | 2 days | Goncalves JoanaChief Medical Officer | SSale | −2.99K | $11.27 | −$33.7K | −4.0%71.9K after | |
| Dec 23, 2022 (view filing) | Dec 21 | 2 days | Terrillion ScottSec'y; Chief Compliance & G.C. | SSale | −2.56K | $11.27 | −$28.9K | −2.5%99.8K after | |
| Nov 18, 2022 (view filing) | Nov 16 | 2 days | Posner ChristopherPresident and CEO | SSale | −14.5K | $11.13 | −$161.1K | −7.2%186.6K after | |
| Sep 16, 2022 (view filing) | Sep 14 | 2 days | Vogelbaum MartinDirector | SSale | −10.8K | $10.28 | −$111.0K | −19.4%45.0K after | |
| Jul 19, 2022 (view filing) | Jul 15 | 4 days | Ives Jeffrey L.Director | SSale | −3.60K | $9.05 | −$32.6K | −18.9%15.5K after | |
| Jul 19, 2022 (view filing) | Jul 15 | 4 days | Bains Harrison M JrDirector | SSale | −7.20K | $9.05 | −$65.2K | −22.3%25.1K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Terrillion ScottSec'y; Chief Compliance & G.C. | SSale | −1.64K | $11.91 | −$19.6K | −1.6%102.3K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Goncalves JoanaChief Medical Officer | SSale | −1.64K | $11.91 | −$19.6K | −2.1%74.9K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D | SSale | −1.78K | $11.91 | −$21.2K | −1.0%169.8K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Posner ChristopherPresident and CEO | SSale | −2.01K | $12.67 | −$25.4K | −1.0%201.0K after | |
| Mar 4, 2022 (view filing) | Mar 3 | 1 day | Reilly Thomas CharlesChief Financial Officer | SSale | −2.04K | $11.38 | −$23.3K | −5.1%37.8K after | |
| Mar 4, 2022 (view filing) | Mar 3 | 1 day | Terrillion ScottSec'y; Chief Compliance & G.C. | SSale | −1.79K | $11.38 | −$20.3K | −1.7%104.0K after | |
| Mar 1, 2022 (view filing) | Feb 25 | 4 days | Terrillion ScottSec'y; Chief Compliance & G.C. | SSale | −1.97K | $10.29 | −$20.3K | −1.9%100.4K after | |
| Mar 1, 2022 (view filing) | Feb 25 | 4 days | Menzaghi Frederique Ph.D.Chief Scientific Off,SVP-R&D | SSale | −2.11K | $10.29 | −$21.8K | −1.2%171.6K after | |
| Mar 1, 2022 (view filing) | Feb 25 | 4 days | Goncalves JoanaChief Medical Officer | SSale | −1.97K | $10.29 | −$20.3K | −2.5%76.5K after | |
| Nov 16, 2021 (view filing) | Nov 12 | 4 days | Ives Jeffrey L.Director | SSale | −8.18K | $16.04 | −$131.2K | −53.2%7.20K after |